African countries are encouraged to establish prospective multicenter cohorts of CKD patients such as the CRIC (Chronic Renal Insufficiency Cohort) Study [44], in order to examine risk factors for CKD progression and CVD tailored to their region, identify high-risk subgroups, and assess the role of genetic factors such as Apolipoprotein L1 (ApoL1) [45] variants in the genesis and progression of CKD in people living on the African continent. This evidence concerns the gene APOL1 and chronic kidney disease.